Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines
- PMID: 34647956
- DOI: 10.1001/jama.2021.18143
Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines
Similar articles
-
Audio Interview: How Well Are Covid-19 Vaccines Working?N Engl J Med. 2021 Jul 8;385(2):e15. doi: 10.1056/NEJMe2111369. N Engl J Med. 2021. PMID: 34233102 No abstract available.
-
Audio Interview: Are Covid-19 Vaccine Boosters Necessary?N Engl J Med. 2021 Oct 7;385(15):e63. doi: 10.1056/NEJMe2115835. N Engl J Med. 2021. PMID: 34614335 No abstract available.
-
Audio Interview: A New mRNA Vaccine.N Engl J Med. 2021 Jun 24;384(25):e109. doi: 10.1056/NEJMe2110531. N Engl J Med. 2021. PMID: 34161714 No abstract available.
-
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.Vaccine. 2021 Jan 8;39(2):197-201. doi: 10.1016/j.vaccine.2020.11.054. Epub 2020 Nov 24. Vaccine. 2021. PMID: 33279318 Free PMC article. Review.
-
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges.ACS Nano. 2024 Sep 10;18(36):24650-24681. doi: 10.1021/acsnano.3c10797. Epub 2024 Aug 26. ACS Nano. 2024. PMID: 39185745 Free PMC article. Review.
Cited by
-
Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques.Vaccines (Basel). 2024 Apr 10;12(4):404. doi: 10.3390/vaccines12040404. Vaccines (Basel). 2024. PMID: 38675786 Free PMC article.
-
Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both.Sci Rep. 2023 Dec 4;13(1):21390. doi: 10.1038/s41598-023-48397-7. Sci Rep. 2023. PMID: 38049498 Free PMC article.
-
Current GMP standards for the production of vaccines and antibodies: An overview.Front Public Health. 2022 Nov 3;10:1021905. doi: 10.3389/fpubh.2022.1021905. eCollection 2022. Front Public Health. 2022. PMID: 36743162 Free PMC article. Review.
-
Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial.Emerg Microbes Infect. 2023 Dec;12(1):2155251. doi: 10.1080/22221751.2022.2155251. Emerg Microbes Infect. 2023. PMID: 36503413 Free PMC article. Clinical Trial.
-
A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination.Vaccines (Basel). 2022 Oct 11;10(10):1694. doi: 10.3390/vaccines10101694. Vaccines (Basel). 2022. PMID: 36298559 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
